3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
11
Prostatic Neoplasms
7
Fallopian Tube Neoplasms
5
Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms, Castration-Resistant
2
Neoplasm Metastasis
2
Glioblastoma
2
Carcinoma, Ovarian Epithelial
2
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Prostate Adenocarcinoma
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Castration-sensitive Prostate Cancer
1
Lung Neoplasms
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Disease Progression
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Cyclophosphamide
25
fludarabine
19
Dexamethasone
17
pembrolizumab
13
Rituximab
12
venetoclax
9
Lenalidomide
9
Gemcitabine
9
Etoposide
9
pomalidomide
8
Vincristine
7
glofitamab
6
fludarabine phosphate
6
carfilzomib
6
Temozolomide
6
obinutuzumab
5
daratumumab
5
Prednisone
5
Nivolumab
5
Doxorubicin
5
Cisplatin
5
Calcium Dobesilate
5
Bortezomib
5
zanubrutinib
4
selinexor
4
Immunotherapy, Adoptive
4
Cytarabine
4
Carboplatin
4
Azacitidine
4
ruxolitinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
niraparib
×
90 days
×
Clear all
No trials found.